サマリー

体外診断用医薬品市場の成長とトレンド

Grand View Research, Inc.の新しいレポートによると、体外診断の世界市場規模は2030年までに1133億8000万米ドルに達すると予測されています。老年人口の増加、COVID-19の大流行、採用を支える診断の技術的進歩が原動力となり、予測期間中にCAGR0.2%を記録すると推定されます。携帯性、正確性、費用対効果という点での技術的進歩は、インパクトの大きいレンダリングドライバーの1つとなると予測されます。技術的進歩は、COVID-19 IVD診断薬の発売によってさらに加速され、PCRなどの技術に対応する機器や消耗品の採用が強化されました。市場の競合他社は、メーカーとユーザーのビジネスの流れを一定に保つために、契約やパートナーシップ戦略を採用するようになってきています。

また、これらの契約は、政府の研究所に対する厳しい価格抑制戦略の結果であり、政府の設定において価格を下げている。例えば、2021年4月、Seegene社のイタリア子会社は、抽出試薬の供給、および715万件のSARS-CoV-2診断テストについて、公共調達のための1億825万米ドルの入札を受けた。しかし、それはサプライチェーンの多者間関係と複雑さを増大させる。癌と心血管疾患（CVD）の世界的な有病率の高さから、早期診断を促進し、常に進化する消費者のニーズに応えるために、診断技術の革新が進むと予想されます。プラズモニックPCRなどの新技術が予測期間中に商業的に市場に参入し、既存製品のビジネスに悪影響を及ぼすと予想されます。

体外診断薬市場レポートハイライト

- 分子診断薬は、導入率と利用率の上昇により、2022年から2030年にかけて最も速いCAGRで成長すると予想される

- 遺伝子検査需要の急増と、未充足の臨床ニーズを抱える中低所得国での技術的に高度な診断テストの利用可能性の向上により、試薬が最大の市場シェアを占めた

- 感染症アプリケーションは、世界的に感染症検査が盛んであることから、最大のシェアを獲得

- 2021年の世界市場は、新規技術への高い需要、多くの主要プレイヤー、高い疾患罹患率、高度な医療インフラにより、北米が支配的な市場となっている

ページTOPに戻る

目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.12 List Of Abbreviations
Chapter 2 Market Definitions
Chapter 3 Executive Summary
3.1 Market Summary
Chapter 4 Global IVD Market Variables, Trends, & Scope
4.1 IVD Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration And Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Growing Geriatric Population
4.4.2 Technological Advancements
4.4.3 Increasing Demand For Poc Facilities
4.4.4 Growing Prevalence Of Target Diseases, Such As Genetic, Cardiovascular, & Neurological Diseases, And Hospital-Acquired Infections
4.4.5 Outbreak Of Covid-19
4.5 Market Restraint Analysis
4.5.1 Higher Cost Of Devices
4.5.2 Stringent Regulatory Policies
4.6 Value Chain Analysis
4.6.1 Value Chain Analysis/Route To Market
4.7 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
4.8 Porter’s Five Forces Analysis
4.9 Consumer Behavior Analysis
4.10 Major Deals and Strategic Alliances Analysis
4.10.1 New product launch
4.10.1.1 Mergers and acquisitions
4.10.1.2 Expansion
4.10.1.3 Partnerships
4.10.1.4 Marketing & promotions
4.10.1.5 Market entry strategies
4.10.2 Mergers And Deals
Chapter 5 IVD Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
5.1 In Vitro Diagnostic Market: Products Movement Analysis
5.2 Instruments
5.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands
5.3 Reagents
5.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Reagents Sold In Million
5.4 Services
5.4.1 Services Market Estimates And Forecast, 2018 - 2030 USD Million
Chapter 6 IVD Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million)
6.1 In Vitro Diagnostics Market: Technology Movement Analysis
6.2 Immunoassay
6.2.1 Immunoassay Market Estimates And Forecast, 2018 - 2030 USD Million
6.2.2 Instruments
6.2.2.1 Instruments Market For Immunoassay Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands
6.2.3 Reagents
6.2.3.1 Reagents Market For Immunoassay Estimates And Forecast, 2018 - 2030 USD Million, Number Of Reagents Sold In Million
6.2.4 Services
6.2.4.1 Services Market for immunoassay estimates and forecast, 2018 - 2030 USD Million
6.3 Hematology
6.3.1 Hematology Market estimates and forecast, 2018 - 2030 USD Million
6.3.2 Instruments
6.3.2.1 Instruments market for hematology estimates and forecast, 2018 - 2030 USD Million, Number of instruments installed in thousands
6.3.3 Reagents
6.3.3.1 Reagents market for hematology estimates and forecast, 2018 - 2030 USD Million, Number of reagents sold in million
6.3.4 Services
6.3.4.1 Services market for hematology estimates and forecast, 2018 - 2030 USD Million
6.4 Clinical Chemistry
6.4.1 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 USD Million
6.4.2 Instruments
6.4.2.1 Instruments Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands
6.4.3 Reagents
6.4.3.1 Reagents Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 USD Million, Number Of Reagents Sold In Million
6.4.4 Services
6.4.4.1 Services market for clinical chemistry estimates and forecast, 2018 - 2030 USD Million
6.5 Molecular Diagnostics
6.5.1 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 USD Million
6.5.2 Instruments
6.5.2.1 Instruments Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands
6.5.3 Reagents
6.5.3.1 Reagents Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 USD Million, Number Of Reagents Sold In Million
6.5.4 Services
6.5.4.1 Services market for molecular diagnostics estimates and forecast, 2018 - 2030 USD Million
6.6 Coagulation
6.6.1 Coagulation Market Estimates And Forecast, 2018 - 2030 USD Million
6.6.2 Instruments
6.6.2.1 Instruments Market For Coagulation Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands
6.6.3 Reagents
6.6.3.1 Reagents Market For Coagulation Estimates And Forecast, 2018 - 2030 USD Million, Number Of Reagents Sold In Million
6.6.4 Services
6.6.4.1 Services Market For Coagulation Estimates And Forecast, 2018 - 2030 USD Million
6.7 Microbiology
6.7.1 Microbiology Market Estimates And Forecast, 2018 - 2030 USD Million
6.7.2 Instruments
6.7.2.1 Instruments Market For Microbiology Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands
6.7.3 Reagents
6.7.3.1 Reagents Market For Microbiology Estimates And Forecast, 2018 - 2030 USD Million, Number Of Reagents Sold In Million
6.7.4 Services
6.7.4.1 Services market for microbiology estimates and forecast, 2018 - 2030 USD Million
6.8 Others
6.8.1 Others Market Estimates And Forecast, 2018 - 2030 USD Million
6.8.2 Instruments
6.8.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands
6.8.3 Reagents
6.8.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Reagents Sold In Million
6.8.4 Services
6.8.4.1 Services market estimates and forecast, 2018 - 2030 USD Million
Chapter 7 IVD Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
7.1 In Vitro Diagnostic Market: Application Movement Analysis
7.2 Infectious Diseases
7.2.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 USD Million
7.3 Diabetes
7.3.1 Diabetes Market Estimates And Forecast, 2018 - 2030 USD Million
7.4 Oncology
7.4.1 Oncology Market Estimates And Forecast, 2018 - 2030 USD Million
7.5 Cardiology
7.5.1 Cardiology Market Estimates And Forecast, 2018 - 2030 USD Million
7.6 Nephrology
7.6.1 Nephrology Market Estimates And Forecast, 2018 - 2030 USD Million
7.7 Autoimmune Diseases
7.7.1 Autoimmune Diseases Market Estimates And Forecast, 2018 - 2030 USD Million
7.8 Drug Testing
7.8.1 Drug Testing Market Estimates And Forecast, 2018 - 2030 USD Million
7.9 Others
7.9.1 Others Market Estimates And Forecast, 2018 - 2030 USD Million
Chapter 8 IVD Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)
8.1 In Vitro Diagnostic Market: End-use Movement Analysis
8.2 Hospitals
8.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
8.3 Laboratory
8.3.1 Laboratory Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
8.4 Home Care
8.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
8.5 Others
8.5.1 Other Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
Chapter 9 IVD Market - Segment Analysis, by Test Location, 2018 - 2030 (USD Million)
9.1 In Vitro Diagnostic Market: Test Location Movement Analysis
9.2 Point Of Care
9.2.1 Point-Of-Care Market Estimates And Forecast, 2018 - 2030 USD Million
9.3 Homecare
9.3.1 Homecare Market Estimates And Forecast, 2018 - 2030 USD Million
9.4 Others
9.4.1 Others Market Estimates And Forecast, 2018 - 2030 USD Million
Chapter 10 IVD Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)
10.1 In Vitro Diagnostic Market: Regional Movement Analysis
10.2 North America
10.2.1 North America, Swot Analysis
10.2.2 North America Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
10.2.3 U.S.
10.2.3.1 U.S. market estimates and forecast, 2018 - 2030 USD Million, Number of instruments installed in thousands, Number of reagents sold in million
10.2.4 Canada
10.2.4.1 Canada market estimates and forecast, 2018 - 2030 USD Million, Number of instruments installed in thousands, Number of reagents sold in million
10.3 Europe
10.3.1 Europe, Swot Analysis
10.3.2 Europe Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
10.3.3 U.K.
10.3.3..1 U.K. Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
10.3.4 Germany
10.3.4.1 Germany Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
10.3.5 Spain
10.3.5.1 Spain Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
10.3.6 France
10.3.6.1 France Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
10.3.7 Italy
10.3.7.1 Italy market estimates and forecast, 2018 - 2030 USD Million, Number of instruments installed in thousands, Number of reagents sold in million
10.3.8 Russia
10.3.8.1 Russia market estimates and forecast, 2018 - 2030 USD Million, Number of instruments installed in thousands, Number of reagents sold in million
10.4 Asia Pacific
10.4.1 Asia Pacific, Swot Analysis
10.4.2 Asia Pacific Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Reagents Sold In Million
10.4.3 Japan
10.4.3.1 Japan market estimates and forecast, 2018 - 2030 USD Million, Number of instruments installed in thousands, Number of reagents sold in million
10.4.4 China
10.4.4.1 China market estimates and forecast, 2018 - 2030 USD Million, Number of instruments installed in thousands, Number of reagents sold in million
10.4.5 INDIA
10.4.5.1 India market estimates and forecast, 2018 - 2030 USD Million Number of instruments installed in thousands, Number of reagents sold in million
10.4.6 South Korea
10.4.6.1 South Korea market estimates and forecast, 2018 - 2030 USD Million Number of instruments installed in thousands, Number of reagents sold in million
10.4.7 Singapore
10.4.7.1 Singapore Market Estimates And Forecast, 2018 - 2030 USD Million Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
10.4.8 Australia
10.4.8.1 Australia market estimates and forecast, 2018 - 2030 USD Million Number of instruments installed in thousands, Number of reagents sold in million
10.5 Latin America
10.5.1 Latin America, Swot Analysis
10.5.2 Latin America Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
10.5.3 Brazil
10.5.3.1 Brazil Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
10.5.4 Mexico
10.5.4.1 Mexico Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
10.5.5 Argentina
10.5.5.1 Argentina market estimates and forecast, 2018 - 2030 USD Million, Number of instruments installed in thousands, Number of reagents sold in million
10.6 Middle East and Africa
10.6.1 Middle East & Africa, Swot Analysis
10.6.2 Middle-East And Africa Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
10.6.3 South Africa
10.6.3.1 South Africa Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
10.6.4 United Arab Emirates
10.6.4.1 United Arab Emirates Market Estimates And Forecast, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands, Number Of Reagents Sold In Million
10.6.5 Saudi Arabia
10.6.5.1 Saudi Arabia market estimates and forecast, 2018 - 2030 USD Million, Number of instruments installed in thousands, Number of reagents sold in million
Chapter 11 Competitive Analysis
11.1 Recent Developments & Impact Analysis, By Key Market Participants
11.1.1 Ansoff Matrix
11.1.2 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
11.1.3 Innovators
11.2 Vendor Landscape
11.2.1 List Of Key Distributors And Channel Partners
11.2.2 Global IVD Market: Key Company Market Share Analysis, 2021
11.3 Mass Spectrometry
11.3.1 Global Clinical Mass Spectrometry Company Market Share Analysis, 2021
11.3.2 North America Clinical Mass Spectrometry Company Market Share Analysis, 2021
11.3.3 Europe Clinical Mass Spectrometry Company Market Share Analysis, 2021
11.3.4 Asia Pacific Clinical Mass Spectrometry Company Market Share Analysis, 2021
11.4 Immunoassay
11.4.1 Global Clinical Immunoassay Company Market Share Analysis, 2021
11.4.2 North America Clinical Immunoassay Company Market Share Analysis, 2021
11.4.3 Europe Clinical Immunoassay Company Market Share Analysis, 2021
11.4.4 Asia Pacific Clinical Immunoassay Company Market Share Analysis, 2021
11.5 Pcr
11.5.1 Global Clinical Pcr Company Market Share Analysis, 2021
11.5.2 North America Clinical Pcr Company Market Share Analysis, 2021
11.5.3 Europe Clinical Pcr Company Market Share Analysis, 2021
11.5.4 Asia Pacific Clinical Pcr Company Market Share Analysis, 2020
11.6 Public Companies
11.6.1 Company Market Position Analysis
11.6.2 Competitive Dashboard Analysis
11.6.3 Strategic Framework
11.7 Private Companies
11.7.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
11.7.2 Regional Network Map
11.8 Company Profiles
11.8.1 ABBOTT
11.8.1.1 Company Overview
11.8.1.2 Alere, Inc.
11.8.1.3 Financial Performance
11.8.1.4 Product Benchmarking
11.8.1.5 Strategic Initiatives
11.8.2 BIOMÉRIEUX SA
11.8.2.1 Company Overview
11.8.2.2 Financial Performance
11.8.2.3 Product Benchmarking
11.8.2.4 Strategic Initiatives
11.8.3 BIO-RAD LABORATORIES, INC.
11.8.3.1 Company Overview
11.8.3.2 Financial Performance
11.8.3.3 Product Benchmarking
11.8.3.4 Strategic Initiatives
11.8.4 BECTON, DICKINSON AND COMPANY
11.8.4.1 Company Overview
11.8.4.2 Financial Performance
11.8.4.3 Product Benchmarking
11.8.4.4 Strategic Initiatives
11.8.5 SIEMENS HEALTHINEERS AG
11.8.5.1 Company Overview
11.8.5.2 Financial Performance
11.8.5.3 Product Benchmarking
11.8.5.4 Strategic Initiatives
11.8.6 QIAGEN
11.8.6.1 Company Overview
11.8.6.2 Financial Performance
11.8.6.3 Product Benchmarking
11.8.6.4 Strategic Initiatives
11.8.7 QUIDEL CORPORATION
11.8.7.1 Company Overview
11.8.7.2 Financial Performance
11.8.7.3 Product Benchmarking
11.8.7.4 Strategic Initiatives
11.8.8 F. HOFFMANN-LA ROCHE LTD.
11.8.8.1 Company Overview
11.8.8.2 Financial Performance
11.8.8.3 Product Benchmarking
11.8.8.4 Strategic Initiatives
11.8.9 SYSMEX CORPORATION
11.8.9.1 Company Overview
11.8.9.2 Financial Performance
11.8.9.3 Product Benchmarking
11.8.9.4 Strategic Initiatives
11.8.10 CHARLES RIVER LABORATORIES
11.8.10.1 Company Overview
11.8.10.2 Financial Performance
11.8.10.3 Product Benchmarking
11.8.10.4 Strategic Initiatives
11.8.11 QUEST DIAGNOSTICS
11.8.11.1 Company Overview
11.8.11.2 Financial Performance
11.8.11.3 Product Benchmarking
11.8.11.4 Strategic Initiatives
11.8.12 AGILENT TECHNOLOGIES, INC.
11.8.12.1 Company Overview
11.8.12.2 Financial Performance
11.8.12.3 Product Benchmarking
11.8.12.4 Strategic Initiatives
11.8.13 DANAHER CORPORATION
11.8.13.1 Company Overview
11.8.13.2 Cepheid
11.8.13.3 Beckman Coulter
11.8.13.4 Leica Biosystems
11.8.13.5 Financial Performance
11.8.13.6 Product Benchmarking
11.8.13.7 Strategic Initiatives
11.8.13.8 Strategic Initiatives- Beckman Coulter, Inc.
11.8.13.9 Strategic Initiatives- Leica Biosystems